BRAIN Initiative: Exploratory Research Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required) (RFA-DC-24-001)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) (PAR-23-164)

Sponsor: National Institute of Mental Health, National Institute on Aging

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) (RFA-NS-24-004)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $10,000,000 per year to fund 15-20 awards.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) (RFA-NS-24-005)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $10,000,000 per year to fund 15-20 awards.

Due Date: Multiple dates; see announcement.

Notice of Special Interest (NOSI): Small Business Digital Technologies for Early Detection, Characterization and Monitoring of Senescence-Related Changes (NOT-AG-23-004)

Sponsor: National Institute on Aging

Due Date: See announcement.

Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) (PAR-23-112)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) (PAR-23-084)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed) (PAR-23-073)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) (PAR-23-082)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (PAR-23-081)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

Notice of NINDS Specific Interest in AD/ADRD for PAS-22-196 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)" (NOT-NS-23-049)

Sponsor: National Institute of Neurological Disorders and Stroke

Notice of NINDS Specific Interest in AD/ADRD for PAS-22-197 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)" (NOT-NS-23-050)

Sponsor: National Institute of Neurological Disorders and Stroke

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) (PAR-23-072)

Sponsor: Food and Drug Administration

Due Date: Multiple due dates; see announcement.

Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) (PAR-23-054)

Sponsor: National Institute on Aging, Office of Research on Women's Health

Due Date: Multiple due dates; see announcement.

Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) (PAR-24-022)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.